Alantos Pharmaceuticals

ShangPharma appoints Arthur Taveras president and CSO

Monday, October 28, 2013

CRO ShangPharma has announced that Dr. Arthur Taveras will join the company as president and chief scientific officer. Taveras brings pharmaceutical leadership and technical experience in drug discovery, chemistry R&D and pharmaceutical development having worked as a pharmaceutical and biotech executive during his 24 year career.

[Read More]